 |
|
Measles Elimination in the AmericasEvolving Strategies
Ciro A. de Quadros, MD, MPH;
Jean Marc Olivé, MD, MPH;
Bradley S. Hersh, MD, MPH;
Marc A. Strassburg, MPH, DrPH;
Donald A. Henderson, MD, MPH;
David Brandling-Bennett, MD, DTPH;
George A. O. Alleyne, MD, FRCP, DSc
JAMA. 1996;275(3):224-229.
Abstract
| |
The strategy currently used to control measles in most countries has been to immunize each successive birth cohort through the routine health services delivery system. While measles vaccine coverage has increased markedly, significant measles outbreaks have continued to recur. During the past 5 years, experience in the Americas suggests that measles transmission has been interrupted in a number of countries (Cuba, Chile, and countries in the English-speaking Caribbean and successfully controlled in all remaining countries. Since 1991 these countries have implemented one-time "catch-up" vaccination campaigns (conducted during a short period, usually 1 week to 1 month, and targeting all children 9 months through 14 years of age, regardless of previous vaccination status or measles disease history). These campaigns have been followed by improvements in routine vaccination services and in surveillance systems, so that the progress of the measles elimination efforts can be sustained and monitored. Follow-up mass vaccination campaigns for children younger than 5 years are planned to take place every 3 to 5 years.
(JAMA. 1996;275:224-229)
Author Affiliations
From the Special Program for Vaccines and Immunization (Drs de Quadros and Hersh) and the Offices of the Deputy Director (Dr Brandling-Bennett) and Director (Dr Alleyne), Pan American Health Organization, Washington, DC; Global Program for Vaccines, World Health Organization, Geneva, Switzerland (Dr Olivé); Los Angeles County Health Department, Los Angeles, Calif (Dr Strassburg), Los Angeles, Calif and Department of International Health and Epidemiology, The Johns Hopkins School of Hygiene and Public Health, Baltimore, Md (Dr Henderson). Dr Olivé was formerly with the Expanded Program on Immunization, Pan American Health Organization, Washington, DC.
Footnotes
Reprint requests to Special Program for Vaccines and Immunization, Pan American Health Organization, 525 E 23rd St NW, Washington, DC 20037 (Dr de Quadros).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Protective efficacy of standard Edmonston-Zagreb measles vaccination in infants aged 4.5 months: interim analysis of a randomised clinical trial
Martins et al.
BMJ 2008;337:a661-a661.
ABSTRACT
| FULL TEXT
Measles in developing countries
Halsey
BMJ 2006;333:1234-1234.
FULL TEXT
MMR Vaccination and Febrile Seizures: Evaluation of Susceptible Subgroups and Long-term Prognosis
Vestergaard et al.
JAMA 2004;292:351-357.
ABSTRACT
| FULL TEXT
Progress Toward Measles Elimination--Region of the Americas, 2002-2003
JAMA 2004;291:2535-2537.
FULL TEXT
The risk of aseptic meningitis associated with the Leningrad-Zagreb mumps vaccine strain following mass vaccination with measles-mumps-rubella vaccine, Rio Grande do Sul, Brazil, 1997
da Silveira et al.
Int J Epidemiol 2002;31:978-982.
ABSTRACT
| FULL TEXT
Results of the Expanded Program on Immunization in the Macedonian Refugee Camps
Koop et al.
AJPH 2001;91:1656-1659.
ABSTRACT
| FULL TEXT
Global Measles Control and Regional Elimination, 1998-1999
JAMA 2000;283:472-474.
FULL TEXT
Performance of Indirect Immunoglobulin M (IgM) Serology Tests and IgM Capture Assays for Laboratory Diagnosis of Measles
Ratnam et al.
J. Clin. Microbiol. 2000;38:99-104.
ABSTRACT
| FULL TEXT
Edmonston-Zagreb Measles Vaccine: A Good Vaccine With an Image Problem
Bennett et al.
Pediatrics 1999;104:1123-1123.
FULL TEXT
Lessons Learned From a Review of the Development of Selected Vaccines
Committee
Pediatrics 1999;104:942-950.
ABSTRACT
| FULL TEXT
Progress Toward Elimination of Measles From the Americas
JAMA 1998;279:1154-1155.
FULL TEXT
Should measles be eradicated?
Cutts and Steinglass
BMJ 1998;316:765-767.
FULL TEXT
Age for Routine Administration of the Second Dose of Measles-Mumps-Rubella Vaccine
Committee on Infectious Diseases
Pediatrics 1998;101:129-133.
ABSTRACT
| FULL TEXT
Progress Toward Global Measles Control and Elimination, 1990-1996
JAMA 1997;278:1396-1397.
ABSTRACT
Harmony on the Second Dose of Measles Vaccine
Katz
Pediatrics 1997;100:891-891.
FULL TEXT
Trends in Importation of Measles to the United States, 1986-1994
Vitek et al.
JAMA 1997;277:1952-1956.
ABSTRACT
Measles--United States, 1996, and the Interruption of Indigenous Transmission
JAMA 1997;277:1345-1346.
ABSTRACT
Measles Outbreak Among School-Aged Children--Juneau, Alaska, 1996
JAMA 1996;276:1294-1295.
ABSTRACT
Measles Elimination In the Americas
Gay and Nokes
JAMA 1996;275:1311-1312.
ABSTRACT
Infectious Diseases: A Global Approach to a Global Problem
Winker and Flanagin
JAMA 1996;275:245-246.
ABSTRACT
|
